Clinical Trial Update: Study of RNS60 on Pain and Function After Hip Labral Repair [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating RNS60 for pain and function after hip labral repair has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Labral Tear

Drugs mentioned

• RNS60

Snippet

Sponsor: Revalesio Corporation | Conditions: Hip Labral Tear | Phase 2 | Status: WITHDRAWN